一、行情表现 1月5日，脑机接口板块开盘大涨。三博脑科（20CM）、岩山科技、创新医疗、南京熊猫等集体一字板，塞力医疗、盈趣科技、翔宇医疗（20CM）、荣泰 健康、国际医学、爱朋医疗（20CM）、熵基科技（20CM）、麦澜德（20CM）、诚益通（20CM）、伟思医疗（20CM）、迈普医学（20CM）等集体涨 停。 | 脑科学 +12.41% | | | | | | | | --- | --- | --- | --- | --- | --- | --- | | 理由 | | 马斯克旗下脑机接口公司2026年将启动脑机接口设备"大规模生产" | | | | | | 股票名称 | 最新价 = | 涨跌幅 = | 涨停时间 = | 换手率 = | 流通市值 ◆ | 解读 | | 三博脑科 | 70.78 | +20.01% | 09:25:00 | 6.18% | 113.92 乙 | 公司是以神经专科为特色的医疗服务集 | | 301293.SZ | | | | | | 院,其中神经专科医院4家,综合性医院 | | 美好医疗 | | | | | 107.71亿 | 公司正与下游脑机接口客户开展产品合 批量出货的商业 ...

SPD概念板块领跌，下跌1.02%，其中合富中国下跌5.04%，英特集团下跌2.8%，塞力医疗下跌1.15%。 （AI生成） ...

Market Overview - The pharmaceutical commercial sector experienced a slight decline of 0.0% on December 30, with Saily Medical leading the drop [1] - The Shanghai Composite Index closed at 3965.12, also down by 0.0%, while the Shenzhen Component Index rose by 0.49% to 13604.07 [1] Stock Performance - Notable gainers in the pharmaceutical sector included: - Yingte Group (000411) with a closing price of 13.23, up by 9.98% and a trading volume of 419,800 shares [1] - Yao Yigou (300937) at 35.65, up by 7.64% with 125,700 shares traded [1] - HeFu China (603122) at 26.00, up by 6.17% with a trading volume of 985,200 shares [1] - Conversely, Saily Medical (603716) saw a decline of 3.19% to a closing price of 20.95, with a trading volume of 123,200 shares [2] Capital Flow - The pharmaceutical commercial sector saw a net inflow of 258 million yuan from institutional investors, while retail investors contributed a net inflow of 54.61 million yuan [2] - Notable capital flows included: - HeFu China (603122) with a net inflow of 286 million yuan from institutional investors [3] - Yingte Group (000411) with a net inflow of 134 million yuan from institutional investors [3] - Yao Yigou (300937) with a net inflow of 16.36 million yuan from institutional investors [3]

Core Viewpoint - The company, Selys Medical Technology Group Co., Ltd., is undergoing changes in its business scope and governance structure, with a focus on expanding into new product categories and preparing for a shareholder meeting to approve these changes [2][4][6]. Group 1: Stock Performance - As of December 26, 2025, Selys Medical's stock closed at 21.48 yuan, down 4.06% from the previous week's 22.39 yuan [1]. - The stock reached a high of 22.5 yuan and a low of 21.16 yuan on December 25, 2025 [1]. - The company's current total market capitalization is 4.515 billion yuan, ranking 24th out of 32 in the pharmaceutical commercial sector and 3628th out of 5178 in the A-share market [1]. Group 2: Corporate Announcements - The fifth board of directors held its 24th meeting on December 22, 2025, where it approved two key resolutions: one to expand the company's business scope and another to convene the first extraordinary general meeting of shareholders in 2026 [2][4]. - The company plans to hold the first extraordinary general meeting of shareholders on January 7, 2026, with both on-site and online voting options available [3][6]. - The proposed expansion of the business scope includes health products, cosmetics, daily chemical products, personal hygiene products, special medical purpose formula foods, pre-packaged foods, health foods, and internet sales [4][6]. Group 3: Corporate Governance - The company's articles of association were revised in December 2025, establishing it as a perpetual joint-stock company with a registered capital of 210,139,246 yuan [5]. - The articles outline shareholder rights and obligations, the powers and rules of the shareholders' meeting, responsibilities of the board of directors and supervisors, and financial accounting policies [5]. - The company aims for a cash dividend priority in profit distribution, with a commitment to distribute no less than 30% of the average distributable profit over the last three years [5].

Core Viewpoint - The stock of Sely Medical has experienced a significant increase of 198.75% this year, but has recently shown a decline in trading performance, with a drop of 3.66% over the last five trading days and 21.39% over the last 60 days [1]. Group 1: Stock Performance - As of December 26, Sely Medical's stock price is 21.57 CNY per share, with a market capitalization of 4.534 billion CNY [1]. - The company has seen a net outflow of 17.64 million CNY in principal funds, with large orders buying 11.94 million CNY and selling 30.74 million CNY [1]. - Sely Medical has appeared on the trading leaderboard 37 times this year, with the most recent appearance on August 26, where it recorded a net purchase of 146 million CNY [1]. Group 2: Financial Performance - For the period from January to September 2025, Sely Medical reported a revenue of 857 million CNY, a year-on-year decrease of 39.64%, and a net profit attributable to shareholders of -87.24 million CNY, down 55.72% year-on-year [2]. - The company has not distributed any dividends in the last three years, with a total payout of 27.07 million CNY since its A-share listing [3]. Group 3: Shareholder Information - As of December 10, the number of shareholders for Sely Medical is 70,400, a decrease of 11.22% from the previous period, with an average of 2,986 circulating shares per person, an increase of 12.64% [2]. - Notable institutional shareholders include Caixin Advantage Industry Rotation Mixed Fund, which increased its holdings by 58.48% to 1.2282 million shares, and new entrants such as GF Healthcare Stock A and others [3].

Core Viewpoint - The stock of Sely Medical has experienced a significant increase of 193.77% this year, but has recently shown a decline in the short term, with a drop of 3.15% over the last five trading days and 23.71% over the last 60 days [1] Group 1: Stock Performance - As of December 25, Sely Medical's stock price is 21.21 CNY per share, with a market capitalization of 4.458 billion CNY [1] - The stock has seen a net outflow of 957,700 CNY in principal funds, with large orders buying 4.3736 million CNY (6.41% of total) and selling 5.3313 million CNY (7.81% of total) [1] - The company has appeared on the "Dragon and Tiger List" 37 times this year, with the most recent appearance on August 26, where it recorded a net purchase of 146 million CNY [1] Group 2: Financial Performance - For the period from January to September 2025, Sely Medical reported a revenue of 857 million CNY, a decrease of 39.64% year-on-year, and a net profit attributable to shareholders of -87.2441 million CNY, down 55.72% year-on-year [2] - The company has not distributed any dividends in the last three years, with a total payout of 27.0741 million CNY since its A-share listing [3] Group 3: Shareholder Information - As of December 10, the number of shareholders for Sely Medical is 70,400, a decrease of 11.22% from the previous period, with an average of 2,986 circulating shares per person, an increase of 12.64% [2] - Notable institutional shareholders include Caifutong Advantage Industry Rotation Mixed Fund, which increased its holdings by 58.48% to 1.2282 million shares, and new entrants such as GF Healthcare Stock A and others [3]

12月23日，塞力医疗（维权）盘中下跌2.07%，截至09:43，报21.73元/股，成交6686.61万元，换手率 1.45%，总市值45.67亿元。 资金流向方面，主力资金净流入9615.86元，特大单买入255.92万元，占比3.83%，卖出0.00元，占比 0.00%；大单买入475.66万元，占比7.11%，卖出730.63万元，占比10.93%。 塞力医疗今年以来股价涨200.97%，近5个交易日涨11.38%，近20日涨1.12%，近60日跌22.70%。 今年以来塞力医疗已经37次登上龙虎榜，最近一次登上龙虎榜为8月26日，当日龙虎榜净买入1.46亿 元；买入总计4.89亿元 ，占总成交额比18.85%；卖出总计3.43亿元 ，占总成交额比13.22%。 资料显示，塞力斯医疗科技集团股份有限公司位于湖北省武汉市东西湖区金山大道1310号，成立日期 2004年2月23日，上市日期2016年10月31日，公司主营业务涉及医疗检验集约化营销及服务业务、体外 诊断产品的代理以及自主体外诊断产品的研发、生产和销售。主营业务收入构成为：IVD业务39.91%， SPD业务38.01%，单纯销售22.08% ...

证券日报网讯12月22日晚间，塞力医疗（603716）发布公告称，公司将于2026年1月7日召开2026年第一 次临时股东会。 ...

Group 1 - The core viewpoint of the article highlights that Saily Medical (SH 603716) held its 24th meeting of the fifth board on December 22, 2025, to discuss the expansion of its business scope and corresponding amendments to its articles of association [1] - For the year 2024, Saily Medical's revenue composition is reported as 97.09% from commercial activities and 2.91% from industrial activities [1] - As of the report date, Saily Medical has a market capitalization of 4.7 billion yuan [1] Group 2 - The article also mentions a significant increase in sales for the new energy heavy truck sector, with November sales experiencing a year-on-year growth of 178% [1] - The demand for these trucks is so high that customers are directly visiting factories to expedite orders, indicating a rare market condition not seen in the past decade [1]

塞力斯医疗科技集团股份有限公司 章 程 2025 年 12 月 1 | 第一章 | 总则 3 | | --- | --- | | 第二章 | 经营宗旨和范围 4 | | 第三章 | 股份 5 | | 第一节 | 股份发行 5 | | 第二节 | 股份增减和回购 6 | | 第三节 | 股份转让 7 | | 第四章 | 股东和股东会 8 | | 第一节 | 股东的一般规定 8 | | 第二节 | 控股股东和实际控制人 10 | | 第三节 | 股东会的一般规定 11 | | 第四节 | 股东会的召集 15 | | 第五节 | 股东会的提案与通知 16 | | 第六节 | 股东会的召开 17 | | 第七节 | 股东会的表决和决议 20 | | 第五章 | 董事和董事会 23 | | 第一节 | 董事的一般规定 23 | | 第二节 | 董事会 26 | | 第三节 | 独立董事 31 | | 第四节 | 董事会专门委员会 33 | | 第六章 | 高级管理人员 35 | | 第七章 | 财务会计制度、利润分配和审计 37 | | 第一节 | 财务会计制度 37 | | 第二节 | 内部审计 40 | | 第三节 ...